The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape On-Demand Webinar The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…CertaraSeptember 3, 2025
Comparing the Altis RepliGut Organoid System to MDCK Monolayers in Predicting the Oral Absorption of Lenalidomide Publication Comparing the Altis RepliGut Organoid System to MDCK Monolayers in Predicting the Oral Absorption of Lenalidomide Learn how organoid systems showed higher permeability and better alignment with in vivo lenalidomide bioavailability,…CertaraAugust 30, 2025
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) On-Demand Webinar Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…CertaraAugust 29, 2025
Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers Publication Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers Find out how palbociclib formulations are bioequivalent under fasting and fed conditions using Phoenix WinNonlinCertaraAugust 18, 2025
Relative Bioavailability of Single-Dose Oral Administration of Two SHR7280 Formulations (Dry Suspension and Tablets) in Healthy Chinese Volunteers Publication Relative Bioavailability of Single-Dose Oral Administration of Two SHR7280 Formulations (Dry Suspension and Tablets) in Healthy Chinese Volunteers Explore how Dry suspension and tablet SHR7280 formulations show comparable bioavailability and safety in a…CertaraAugust 8, 2025
Model-based meta-analysis (MBMA) at GSK: Real-world impact on strategy and trials Blog Model-based meta-analysis (MBMA) at GSK: Real-world impact on strategy and trials GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…CertaraJuly 31, 2025
Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese] On-Demand Webinar Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese] The Japanese educational webinar series provides essential insights into in vitro data analysis and the…CertaraJuly 30, 2025
Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development Case Study Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.CertaraJuly 29, 2025
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines On-Demand Webinar MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.CertaraJuly 29, 2025